Data Characteristics
Peptide drug pharmacovigilance data originates from clinical trial reports, real-world evidence (RWE) data, case reports, literature, and regulatory guidelines. This data typically exists as unstructured text (e.g., PDF clinical study reports, Word expert consensus documents) and semi-structured data (e.g., CSV or JSON adverse event reports). Data updates are driven by clinical research progress, regulatory policy changes, and new adverse event discoveries, usually occurring quarterly or annually. Severe adverse event reports may trigger immediate updates. Document structures vary: clinical study reports include sections like background, methods, results, and discussion; adverse event reports contain fields such as patient information, medication history, adverse event description, and outcome, with the adverse event description often being free text. Specialized fields frequently appear, including peptide sequence information, dosage units (e.g., mg/kg), administration routes, and adverse event terminology (e.g., MedDRA codes).
Constraints Imposed by Data Characteristics on Knowledge Base Retrieval
The diverse sources and varying update frequencies of peptide drug data require the knowledge base to have efficient document ingestion and incremental update capabilities. A high proportion of unstructured text limits the effectiveness of traditional keyword matching, necessitating more advanced semantic understanding techniques. The presence of specialized fields like peptide sequences and dosages means that knowledge base segmentation must preserve the integrity of this critical information to avoid semantic loss due to fragmentation. The use of standardized terminology like MedDRA codes suggests that knowledge base processing should consider terminology normalization mapping to improve retrieval accuracy. Furthermore, the complex mechanisms of action and potential immunogenicity of peptide drugs can lead to diverse and subtle adverse reactions, demanding higher relevance and comprehensiveness from retrieval results. The system needs to identify deep semantic connections.
Configuration Settings
| Configuration Item | Recommended Value | Rationale |
|---|---|---|
Chunk size (Chunk Size) | 500–800 characters (characters) | Balances the integrity of specialized information like peptide sequences and dosages with semantic coherence. |
Chunk Overlap | 100 characters (characters) | Ensures context continuity across chunk boundaries, improving the robustness of semantic retrieval. |
Recall count (Retrieval Count) | 10–15 entries (items) | Covers potentially related information, balancing retrieval breadth with subsequent re-ranking efficiency. |
Similarity threshold (Similarity Threshold) | 0.75 | Filters out low-relevance results, reduces noise interference, and improves retrieval precision. |
Rerank result count (Re-ranked Return Count) | 5 entries (items) | Selects the most relevant information for presentation, reduces information overload, and helps engineers quickly focus. |
PARSE_FILE_TIMEOUT_SECONDS | 600 seconds (seconds) | Handles large clinical reports and complex documents, preventing parsing failures due to timeouts. |
Common Pitfalls
- The knowledge base fails to incorporate the latest peptide drug pharmacovigilance guidelines or clinical trial data in a timely manner, leading to outdated retrieval results. This occurs because the knowledge base synchronization mechanism is not configured for automatic fetching or the update frequency is too low, requiring manual updates.
- Retrieval results contain a large number of irrelevant or duplicate adverse reaction reports, making it difficult to filter effective information. This may be due to a
Similarity threshold(Similarity Threshold) set too low, failing to effectively filter out low-quality retrieved items. - When querying the immunogenicity risk of a specific peptide drug, the system returns irrelevant or incomplete results. This may occur if the knowledge base segmentation process severs critical peptide sequence information or related immunological context, leading to inaccurate semantic understanding.
Verification of Configuration
- Conduct regular random sampling tests on the knowledge base. Retrieve recently published peptide drug adverse reaction cases and check if the retrieved results contain key information.
- Simulate engineer queries for known severe adverse reactions of specific peptide drugs. Evaluate the accuracy and completeness of the retrieved results and compare them with expert opinions.
- Monitor knowledge base logs to check document parsing success rates and retrieval request response times. This ensures stable system operation and performance meets requirements.
The values provided are common starting points. Measure them against your own samples.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.